Blokees Debuts New “BLOKEES WHEELS” Category and Exhibits Multiple New Model Kits at Wonder Festival 2025
SHANGHAI, Oct. 2, 2025 /PRNewswire/ -- At Wonder Festival 2025, Assembly Character…
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
Hinge Bio to receive $10 million upfront and is eligible to receive…
Signature Global Strengthens Connection with NRIs in USA’s Rhode Island through Investor Engagement Programme
Signature Global, one of India's leading real estate developers, has strengthened its…
Planette Launches High-Precision Long-Range Weather Forecasting Platform for Finance and Insurance
Planette’s platform, Joro, helps financial insurance industries model extreme weather scenarios where…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…
UPI Launches Program to Extend Payment Network for International Students
HONG KONG, Sept. 17, 2025 /PRNewswire/ -- UnionPay International (UPI), a global leader…
FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient
MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ -- VDF FutureCeuticals, Inc. filed a lawsuit…
TCL Secures Multiple Honors at IFA 2025 with Cutting-edge Smart-Living Solutions
BERLIN, Sept. 10, 2025 /PRNewswire/ -- TCL, a global leader in consumer…
AV-Comparatives Nominated for Euregio Innovation Award at European Forum Alpbach 2025
Research uncovers serious vulnerabilities across multiple devices from two major smart home…